Article Published 16 Oct 2025 Understanding The EU's International Procurement Instrument China Government, Public Sector CM Crowell & Moring LLP
Article Published 15 Oct 2025 汉坤 • 观点 | 《药品管理法实施条例》(修订草案)重点快评 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 中国药品年度报告制度简析 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 15 Oct 2025 汉坤 • 观点 | 简评新版《医疗器械临床试验质量管理规范(GCP)》 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 14 Oct 2025 Compliance Highlights And Strategies In High-Risk Clinical Research Landscape China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 14 Oct 2025 Han Kun • Opinion | Hot Spot Tracking: Daily Regulatory Risk Warnings For Drug Clinical Trial Institutions China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 14 Oct 2025 Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Achievements Of Our Country's Drug Review And Approval System Reform (Part 1) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Interpretation Of The "Detailed Rules For The Supervision Of Internet Diagnosis And Treatment (Trial)" China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Finally Waiting For You - Interpreting The New Policy Of Cross-border Contract Production Of Drugs And Medical Devices In The Guangdong-Hong Kong-Macao Greater Bay Area China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 13 Oct 2025 Han Kun • Opinion | Research On Urban Customized Commercial Medical Insurance China Insurance HK Han Kun Law Offices
Article Published 9 Oct 2025 Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Of Our Country's Drug Review And Approval System (Part II) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 Han Kun • Opinion | Interpretation Of China's Annual Drug Review Report (2015-2021) - Review Of The Reform Achievements Of Our Country's Drug Review And Approval System (Part II) China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 汉坤 • 观点 | 医药BD项目如何友好"分手"? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 How Digital Therapeutics (DTx) Products Are Regulated In China? China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 生命科学行业License-in/out合同争议要点分析(三):不竞争条款 China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 2024 Data Analytics: China Life Sciences NewCo & Licensing Terms China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 9 Oct 2025 Strengthening Oversight of Imported Drugs: Key Takeaways into New Regulations on Domestic Responsible Entities China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 8 Oct 2025 First Drug Patent Term Extension Granted In China China Intellectual Property TM Toby Mak
Article Published 7 Oct 2025 Han Kun • Opinion | Hainan Boao Lecheng Clinical Urgently Needs A Review Of The Highlights Of The New Regulations On The Management Of Imported Drugs And Devices China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices
Article Published 6 Oct 2025 Han Kun • Opinion | Key Points For The Supervision Of Medical And Three-Product And One-Device Advertising Under The New Regulations On Internet Advertising China Food, Drugs, Healthcare, Life Sciences HK Han Kun Law Offices